| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | phenylacetate | 0.4805 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 0.4805 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 0.5763 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 0.6192 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 0.7951 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 0.9615 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 1.0385 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 1.0788 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 1.3562 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 2.3244 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | phenylacetate | 4.1927 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|